Prosecution Insights
Last updated: August 18, 2026

Examiner: RYAN, DOUGLAS CHARLES

Tech Center 1600 • Art Units: 1635 1636

This examiner grants 40% of resolved cases

Performance Statistics

40.3%
Allow Rate
-19.7% vs TC avg
122
Total Applications
+50.7%
Interview Lift
1185
Avg Prosecution Days
Based on 72 resolved cases, 2023–2026

Rejection Statute Breakdown

7.7%
§101 Eligibility
14.4%
§102 Novelty
32.6%
§103 Obviousness
31.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17544527 Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer Non-Final OA The Regents of the University of California
17049320 SPIKED PRIMERS FOR ENRICHMENT OF PATHOGEN NUCLEIC ACIDS AMONG BACKGROUND OF NUCLEIC ACIDS Non-Final OA The Regents of the University of California
18026389 COMPOSITIONS AND METHODS FOR MODULATION OF BACTERIAL GENE EXPRESSION Non-Final OA University of Florida Research Foundation, Incorporated
17097484 OPTOGENETIC CIRCUITS FOR CONTROLLING CHEMICAL AND PROTEIN PRODUCTION IN ESCHERICHIA COLI Non-Final OA THE TRUSTEES OF PRINCETON UNIVERSITY
18965935 NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
17124999 MULTIPLEXED IN VIVO DISEASE SENSING WITH NUCLEIC ACID-BARCODED REPORTERS Final Rejection Massachusetts Institute of Technology
17085937 BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF Final Rejection MASSACHUSETTS INSTITUTE OF TECHNOLOGY
17362038 Method for selecting cells based on CRISPR/Cas-mediated integration of a detectable tag to a target protein Final Rejection Hoffmann-La Roche Inc.
18293099 BC200 RNA DECOY COMPOUNDS AND METHODS OF USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES, INCLUDING LUPUS Non-Final OA The Research Foundation for the State University of New York
18417305 SYNTHETIC YEAST CELLS AND METHODS OF MAKING AND USING THE SAME Final Rejection Wisconsin Alumni Research Foundation
17403317 METHOD FOR PRODUCING MODIFIED OLIGONUCLEOTIDE COMPRISING COMPLEMENTARY PORTION Final Rejection Ajinomoto Co., Inc.
16826010 ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME Non-Final OA Wayne State University
17602411 A Ribozyme Comprising a Target-Binding Domain Final Rejection AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month